1. Main page
  2. Finance & Banking
  3. Viva Biotech

Viva Biotech

4 Decision Makers · 4 Verified Contacts

vivabiotech.com.cn
📍 Shanghai, Shanghai, ChinaFinance & Banking🗓 Est. 2008👥 1001–5000 employees

About Viva Biotech

Viva Biotech is a Healthcare Start Up Based In Shanghai.

Leadership & Decision Makers

Contact details of 4 Viva Biotech decision makers

Cheney Mao

Founder, Chairman, Chief Executive Officer, and Executive Director

Xueheng Cheng

CTO

Yinghong Gao

VP of BD

Fengmao Hua

Executive Director and CFO

General Emails

General company emails, e.g. customer support lines

    info@vivabiotech.com.cn

    General Inquiries

    pitch@vivabiotech.com.cn

    Pitch Deck Inbox

    investor@vivabiotech.com.cn

    Investor Relations

    manager@vivabiotech.com.cn

    Management Department

    sales@vivabiotech.com.cn

    Sales Department

    info@vivabiotech.com

    General Inquiries

    qing.liu@vivabiotech.com.cn

    Unclassified inbox

Verify Viva Biotech Emails

Similar Companies like Viva Biotech

BMO Capital Markets

capitalmarkets.bmo.com
Finance & Banking · Toronto, Ontario, Canada · Est. 1988 · 1001–5000 employees

HQ: Toronto, Ontario, Canada

Bain Capital

baincapital.com
Finance & Banking · Boston, MA · Est. 1984 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

Blackstone Group

blackstone.com
Finance & Banking · New York, NY · Est. 1985 · 251–500 employees

HQ: New York, NY

BMO Nesbitt Burns

bmo.com
Finance & Banking · Toronto, Ontario, Canada · Est. 1987 · 251–500 employees

HQ: Toronto, Ontario, Canada

ThedaCare

thedacare.org
Finance & Banking · Appleton, WI · Est. 1994 · 5001–10000 employees · $100M-$250M

HQ: Appleton, WI

Explore similar firms in the Finance & Banking sector

Company Info

Last updated: 28/07/2025

vivabiotech.com.cn

+86(0)21 6089 3288

Shanghai, Shanghai, China

Legal Name: Viva Biotech (Shanghai) Ltd.
Employees: 1001-5000
Founded Date: 2008
Number of Exits: 2
Company Type: For Profit
Stock Symbol: SEHK:1873
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +86(0)21 6089 3288
Last Investment Activity: Mar 6, 2024
Investments Activity: Mar 6, 2024 Dec 1, 2023 Nov 21, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.